> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Revoking Methods of Analysis Regulation
- URL: https://www.fdaweb.com/fda-revoking-methods-of-analysis-regulation/
- Published: 2022-07-15T12:00:00.000Z
- Updated: 2026-09-14T17:52:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152285

*Federal Register* proposed rule: FDA is proposing to revoke its methods of analysis regulation (21 CFR 2.19) that describes policy to use certain methods of analysis for FDA enforcement programs when the method is not prescribed in a regulation. The agency believes that the regulation is unnecessary. Absent specifying a method of analysis in a regulation, FDA believes it is more appropriate, flexible, and efficient to identify its preferred methods of analysis in documents such as the Office of Regulatory Affairs Laboratory Procedures Manual, FDA compliance programs, and other resources. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-07-15/pdf/2022-15109.pdf?ref=fdaweb.com).